KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZRESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc.
J. Jill shares surge after reporting a first-quarter FY24 with a 7.5% sales growth to $161.51 million, surpassing the $154.92 million estimate. The company raised its FY24 sales growth guidance to 1%-3%, and adjusted EPS of $1.22 beat the $0.99 consensus.
Morgan Stanley also forecasts 90 megatons of annual carbon dioxide emission from U.S. data centers by 2027, equivalent to emissions of about 14 million gas cars.
SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces the publication of a